-+ 0.00%
-+ 0.00%
-+ 0.00%

HOPE THERAPEUTICS, AN NRX PHARMACEUTICALS SUBSIDIARY (NASDAQ:NRXP), ANNOUNCES STRATEGIC PARTNERSHIP WITH EMOBOT TO INTEGRATE ITS AI-POWERED “DEPRESSION THERMOMETER” ACROSS ITS INTERVENTIONAL PSYCHIATRY NETWORK

Reuters·03/30/2026 11:00:03

Please log in to view news